Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Chemotherapeutics for Acute Erythroid Leukemia: Research, Present and Future.

Current molecular medicine - 1 Jan 2021

Liao Zexi, Li Jiaxin, Wu Jingjing, Liu Jing, Sun Shuming

Abstract excerpt

Acute erythroid leukemia (AEL) is a subtype of acute myeloid leukemia (AML) with features such as accumulation of maturation-arrested erythroblasts. Compared with AML, the progression of AEL is faster and the prognosis to available therapy is worse. However, its categorization is still being updated and the pathophysiology of AEL is still under research, making diagnosis and chemotherapy challenging for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Differentiation
Share to Leukemia, Erythroblastic, Acute
Share to Mutation

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Neoplasm Proteins

Share to Transcription Factors

Source

Identifiers

PMID: 33475071
DOI: 10.2174/1566524021666210121142316

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Chemotherapeutics for Acute Erythroid Leukemia: Research, Present and Future.PMID 33475071Read ↗

A History and Current Understanding of Acute Erythroid Leukemia.Semantic proximity Read ↗

Acute Erythroid Leukemia: From Molecular Biology to Clinical Outcomes.Semantic proximity Read ↗

Acute erythroid leukemia.Semantic proximity Read ↗

To bi or not to bi: Acute erythroid leukemias and hematopoietic lineage choice.Semantic proximity Read ↗

[Clinical characteristics and prognostic analysis of acute erythroid leukemia].Semantic proximity Read ↗

Acute erythroid leukemia (AEL) can be separated into distinct prognostic subsets based on cytogenetic and molecular genetic characteristicsSemantic proximity Read ↗

Update on current treatments for adult acute myeloid leukemia: to treat acute myeloid leukemia intensively or non-intensively? That is the question.Semantic proximity Read ↗

Revisiting gene mutations and prognosis of ex-M6a-acute erythroid leukemia with regard to the new WHO classificationSemantic proximity Read ↗

[Molecular pathogenesis and therapeutic targets in acute erythroid leukemia].Semantic proximity Read ↗

Advances in acute myeloid leukemia differentiation therapy: A critical reviewSemantic proximity Read ↗

Pure (acute) erythroid leukemia: morphology, immunophenotype, cytogenetics, mutations, treatment details, and survival data among 41 Mayo Clinic cases.Semantic proximity Read ↗

Mixed-phenotype acute leukemia: state-of-the-art of the diagnosis, classification and treatment.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.